Inventor · disambiguated record
Srinivas Rao
Also filed as: RAO SRINIVAS · RAO SRINIVAS G · RAO SRINIVAS GANDHAM
27 granted patents·44 pending applications·283 citations·filing 2001–2024
96Inventor score
Files withCYPRESS BIOSCIENCE INC25ATAI Life Sciences AG11SOVA PHARMACEUTICALS INC5US HEALTH5COLLEGIUM PHARMACEUTICAL INC4
Top patents by PatentIndex Score
71 records- 0196US12065405B2Prodrugs and conjugates of dimethyltryptamineATAI THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·4 cites·30 claims
- 0296US11643391B2Prodrugs and conjugates of dimethyltryptamineATAI Life Sciences AG·Filed 2022·Granted May 9, 2023·7 cites·8 claims
- 0396US6992110B2Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and painCYPRESS BIOSCIENCE INC·Filed 2003·Granted Jan 31, 2006·88 cites·6 claims
- 0495US11718647B2Virus-like particles and methods of useUS HEALTH·Filed 2021·Granted Aug 8, 2023·2 cites·14 claims
- 0595US11602521B2N,N-dimethyltryptamine compositions and methodsATAI Life Sciences AG·Filed 2022·Granted Mar 14, 2023·6 cites·27 claims
- 0695US9487563B2Virus-like particles and methods of useNABEL GARY J·Filed 2012·Granted Nov 8, 2016·18 cites·19 claims
- 0795US9353353B2Virus-like particles (VLPs) prepared from chikungunya virus structural proteinsNABEL GARY J·Filed 2009·Granted May 31, 2016·29 cites·9 claims
- 0894US6602911B2Methods of treating fibromyalgiaCYPRESS BIOSCIENCE INC·Filed 2001·Granted Aug 5, 2003·46 cites·7 claims
- 0992US11098084B2Virus-like particles and methods of useTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Aug 24, 2021·3 cites·10 claims
- 1091US11845736B2Prodrugs of MDMA, MDA, and derivatives thereofEMPATHBIO INC·Filed 2022·Granted Dec 19, 2023·2 cites·25 claims
- 1191US10138277B2Virus-like particles and methods of useUS HEALTH·Filed 2016·Granted Nov 27, 2018·3 cites·9 claims
- 1291US6635675B2Method of treating chronic fatigue syndromeCYPRESS BIOSCIENCE INC·Filed 2001·Granted Oct 21, 2003·50 cites·5 claims
- 1391US2025326801A1Virus-like particles and methods of useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 1489US12281336B2Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteinsUS HEALTH·Filed 2024·Granted Apr 22, 2025·0 cites·5 claims
- 1588US12128027B2N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and methods of use thereofATAI THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·4 cites·20 claims
- 1688US10369208B2Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteinsUS HEALTH·Filed 2016·Granted Aug 6, 2019·5 cites·6 claims
- 1787US12168675B2Virus-like particles and methods of useUS HEALTH·Filed 2023·Granted Dec 17, 2024·0 cites·12 claims
- 1885US7704527B2Modified release compositions of milnacipranCOLLEGIUM PHARMACEUTICAL INC·Filed 2008·Granted Apr 27, 2010·8 cites·17 claims
- 1983US7888342B2Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and painCYPRESS BIOSCIENCE INC·Filed 2009·Granted Feb 15, 2011·3 cites·10 claims
- 2080US11992523B2Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteinsTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES THE GOVERNMENT·Filed 2022·Granted May 28, 2024·0 cites·4 claims
- 2177US11369674B2Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteinsTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted Jun 28, 2022·0 cites·7 claims
- 2276US7915246B2Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and painCYPRESS BIOSCIENCE INC·Filed 2008·Granted Mar 29, 2011·1 cites·9 claims
- 2376US2025026731A1Prodrugs of mdma, mda, and derivatives thereofEMPATHBIO INC·Filed 2024·Application pending·0 cites
- 2472US2023041584A1Novel prodrugs and conjugates of dimethyltryptamineATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 2570US2010105778A1Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and painCYPRESS BIOSCIENCE INC·Filed 2009·Application pending·0 cites
- 2670US2010105779A1Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and painCYPRESS BIOSCIENCE INC·Filed 2009·Application pending·0 cites
- 2769US10227314B2Cystathionine-gamma-lyase (CSE) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2017·Granted Mar 12, 2019·1 cites·9 claims
- 2868US8021687B2Modified release compositions of milnacipranCOLLEGIUM PHARMACEUTICAL INC·Filed 2010·Granted Sep 20, 2011·1 cites·30 claims
- 2968US7994220B2Milnacipran for the long-term treatment of fibromyalgia syndromeCYPRESS BIOSCIENCE INC·Filed 2006·Granted Aug 9, 2011·1 cites·7 claims
- 3068US2025205191A1R(-)-mdma compositions and methods of treatmentEMPATHBIO INC·Filed 2024·Application pending·0 cites
- 3167US2024408054A1Compositions and methods for increasing exposure of r(-)-mdaATAI Life Sciences AG·Filed 2024·Application pending·0 cites
- 3266US7820643B2Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and painCYPRESS BIOSCIENCE INC·Filed 2003·Granted Oct 26, 2010·1 cites·8 claims
- 3363US2007225375A1Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and painCYPRESS BIOSCIENCE INC·Filed 2007·Application pending·0 cites
- 3462US2023136824A1N-n-dimethyltryptamine (dmt) and dmt analog compositions, methods of making, and methods of use thereofATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 3562US2024082212A1Use of mdma for treatment of stress-related disordersATAI Life Sciences AG·Filed 2023·Application pending·0 cites
- 3661US2023024991A1Prodrugs of acyl carnitinesATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 3761US2023310374A1Compositions and methods for treating headache or facial painATAI Life Sciences AG·Filed 2023·Application pending·0 cites
- 3860US2010081719A1Milnacipran for the treatment of fatigue associated with fibromyalgia syndromeCYPRESS BIOSCIENCE INC·Filed 2009·Application pending·0 cites
- 3959US2009270373A1Treatment of down syndrom with benzodiazepine receptor antagonistsCYPRESS BIOSCIENCES INC·Filed 2009·Application pending·0 cites
- 4057US2009105222A1Prevention and treatment of functional somatic disorders, including stress-related disordersCYPRESS BIOSCIENCE INC·Filed 2008·Application pending·0 cites
- 4157US2023100844A1Ibogaine combination treatmentATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 4257US2010204205A1Tolerability of mirtazapine and a second active agent by using them in combinationBARAK NIR·Filed 2009·Application pending·0 cites
- 4357US2023099972A1Compositions and methods for treating headachesATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 4457US2023270714A1Salvinorin compositionsATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 4555US2006039866A1Method for treating sleep-related breathing disordersCYPRESS BIOSCIENCE INC·Filed 2005·Application pending·0 cites
- 4655US2009275562A1Tolerability of mirtazapine and a second active by using them in combinationCYPRESS BIOSCIENCES INC·Filed 2009·Application pending·0 cites
- 4755US2006039867A1Method for treating sleep-related breathing disorders with setiptilineCYPRESS BIOSCIENCE INC·Filed 2005·Application pending·0 cites
- 4854US2008058317A1Milnacipran for the treatment of fatigue associated with fibromyalgia syndromeCYPRESS BIOSCIENCE INC·Filed 2007·Application pending·0 cites
- 4954US2010160294A1Tolerability of mirtazapine and a second active by using them in combinationCYPRESS BIOSCIENCES INC·Filed 2009·Application pending·0 cites
- 5054US2005032782A1Treatment of chronic pain associated with drug or radiation therapyCYPRESS BIOSCIENCE INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →